KCT0003286
Recruiting
未知
Gonadotropin-releasing hormone (GnRH) agonist for prevention of chemotherapy induced menopause in malignant ovarian germ cell tumor: a multicenter study
Bundang CHA General Hospital0 sites65 target enrollmentTBD
ConditionsDiseases of The genitoruinary system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of The genitoruinary system
- Sponsor
- Bundang CHA General Hospital
- Enrollment
- 65
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients diagnosed as pathologically malignant germ cell tumors of the ovary. Patients who received
- •at least one ovarian conserved chemotherapy
- •2\) Patients 12 years old (after menarche) \~ 40 years old
Exclusion Criteria
- •1\) Post menpausal women
- •2\) Premenstrual girl
- •3\) Patients with menopause induced by surgery or radiation therapy prior to chemotherapy
- •4\) Patients diagnosed with other carcinoma and underwent chemotherapy and pelvic radiation therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
GnRH-agonist trigger versus HCG trigger in cases of controlled ovariaPACTR202001787868341faculty of medicine alexandria university300
Recruiting
Phase 2
Women undergoing chemotherapy plus gonadotrophin-releasing hormone (GnRH) analouges compared with control to protect ovairan functioWomen of reproductive age receiving chemotherapyCancerReproductive Health and Childbirth - Fertility including in vitro fertilisationCancer - BreastACTRN12609001059257Ass. Prof. Dr. Eman Elgindy100
Unknown
Not Applicable
Antagonist versus agonist protocols: in patients with polycystic ovary syndrome treated for ICSI cyclesFertility-femaleInfertility in PCOS patientsPACTR201411000933365Obestetrics and Gynaecology Department, Faculty of Medicine, University of Alexandria200
Not yet recruiting
Phase 3
GNRH agonist vs GNRH antagonist in infertility treatment.Infertility in endometriosis.EndometriosisIRCT20230403057803N1Shahid Beheshti University of Medical Sciences120
Completed
Not Applicable
Gonadotropin releasing hormone agonist flare-up versus gonatotropin releasing hormone antagonist protocols in poor responders undergoing ICSI:RCTPACTR201704002212265Airforce specialized hospital106